Year |
Citation |
Score |
2024 |
Johnson CB, Walther D, Baggott MJ, Baker LE, Baumann MH. Novel Benzofuran Derivatives Induce Monoamine Release and Substitute for the Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine. The Journal of Pharmacology and Experimental Therapeutics. PMID 38272669 DOI: 10.1124/jpet.123.001837 |
0.301 |
|
2021 |
Thomas AM, Cargile KJ, Lunn JA, Baker LE. Characterization of 3,4-methylenedioxypyrovalerone discrimination in female Sprague-Dawley rats. Behavioural Pharmacology. 32: 524-532. PMID 34397448 DOI: 10.1097/FBP.0000000000000647 |
0.56 |
|
2020 |
Herr KA, Baker LE. Re-evaluation of the discriminative stimulus effects of lysergic acid diethylamide with male and female Sprague-Dawley rats. Behavioural Pharmacology. PMID 32960851 DOI: 10.1097/FBP.0000000000000589 |
0.44 |
|
2020 |
Risca HI, Zuarth-Gonzalez JD, Baker LE. Conditioned place preference following concurrent treatment with 3, 4-Methylenedioxypyrovalerone (MDPV) and methamphetamine in male and female Sprague-Dawley rats. Pharmacology, Biochemistry, and Behavior. 173032. PMID 32888971 DOI: 10.1016/J.Pbb.2020.173032 |
0.743 |
|
2020 |
Kohler RJ, Cibelli J, Baker LE. Combined effects of mephedrone and cocaine on locomotor activity and conditioned place preference in male Sprague-Dawley rats. Behavioural Pharmacology. PMID 32032101 DOI: 10.1097/Fbp.0000000000000539 |
0.6 |
|
2019 |
Bullock TA, Berquist MD, Baker LE. Locomotor sensitization in male Sprague-Dawley rats following repeated concurrent treatment with 4-methylmethcathinone and 3,4-methylenedioxymethamphetamine. Behavioural Pharmacology. PMID 31268871 DOI: 10.1097/Fbp.0000000000000491 |
0.553 |
|
2018 |
Risca HI, Baker LE. Contribution of monoaminergic mechanisms to the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) in Sprague-Dawley rats. Psychopharmacology. PMID 30554256 DOI: 10.1007/S00213-018-5145-8 |
0.748 |
|
2017 |
Kohler RJ, Perrine SA, Baker LE. Concurrent repeated exposure to 3,4-Methylenedioxypyrovalerone and cocaine produce locomotor sensitization with minimal effects on brain monoamines. Neuropharmacology. PMID 29042316 DOI: 10.1016/J.Neuropharm.2017.10.019 |
0.535 |
|
2017 |
Berquist MD, Thompson NA, Baker LE. Evaluation of training dose in male Sprague-Dawley rats trained to discriminate 4-methylmethcathinone. Psychopharmacology. PMID 28815279 DOI: 10.1007/S00213-017-4716-4 |
0.452 |
|
2017 |
Harvey EL, Burroughs RL, Baker LE. Effects of D1 and D2 receptor antagonists on the discriminative stimulus effects of methylendioxypyrovalerone and mephedrone in male Sprague-Dawley rats trained to discriminate D-amphetamine. Behavioural Pharmacology. PMID 28704276 DOI: 10.1097/Fbp.0000000000000328 |
0.79 |
|
2017 |
Berquist MD, Baker LE. Characterization of the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone in male Sprague-Dawley rats. Behavioural Pharmacology. PMID 28598863 DOI: 10.1097/Fbp.0000000000000310 |
0.64 |
|
2017 |
Baker LE. Hallucinogens in Drug Discrimination. Current Topics in Behavioral Neurosciences. PMID 28484970 DOI: 10.1007/7854_2017_476 |
0.434 |
|
2016 |
Berquist MD, Traxler HK, Mahler AM, Baker LE. Sensitization to the locomotor stimulant effects of "bath salt" constituents, 4-methylmethcathinone (4-MMC) and 3,4-methylenedioxypyrovalerone (MDPV), in male Sprague-Dawley rats. Drug and Alcohol Dependence. PMID 27181413 DOI: 10.1016/J.Drugalcdep.2016.05.001 |
0.456 |
|
2015 |
Harvey EL, Baker LE. Differential effects of 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone (mephedrone) in rats trained to discriminate MDMA or a d-amphetamine + MDMA mixture. Psychopharmacology. PMID 26558618 DOI: 10.1007/S00213-015-4142-4 |
0.793 |
|
2015 |
Walters JL, Lansdell TA, Lookingland KJ, Baker LE. The effects of gestational and chronic atrazine exposure on motor behaviors and striatal dopamine in male Sprague-Dawley rats. Toxicology and Applied Pharmacology. PMID 26440580 DOI: 10.1016/J.Taap.2015.09.026 |
0.369 |
|
2015 |
Quisenberry AJ, Baker LE. Dopaminergic mediation of the discriminative stimulus functions of modafinil in rats. Psychopharmacology. PMID 26374456 DOI: 10.1007/S00213-015-4065-0 |
0.775 |
|
2015 |
Berquist MD, Peet MM, Baker LE. Behavioral sensitization following concurrent exposure to mephedrone and D-amphetamine in female mice. Behavioural Pharmacology. 26: 180-3. PMID 25485643 DOI: 10.1097/Fbp.0000000000000121 |
0.473 |
|
2013 |
Quisenberry AJ, Prisinzano T, Baker LE. Combined effects of modafinil and d-amphetamine in male Sprague-Dawley rats trained to discriminate d-amphetamine. Pharmacology, Biochemistry, and Behavior. 110: 208-15. PMID 23880213 DOI: 10.1016/J.Pbb.2013.07.011 |
0.776 |
|
2013 |
Quisenberry AJ, Prisinzano TE, Baker LE. Modafinil alone and in combination with low dose amphetamine does not establish conditioned place preference in male Sprague-Dawley rats. Experimental and Clinical Psychopharmacology. 21: 252-8. PMID 23647093 DOI: 10.1037/A0031832 |
0.765 |
|
2012 |
Lotfizadeh AD, Redner R, Edwards TL, Quisenberry AJ, Baker LE, Poling A. Effects of altering motivation for food in rats trained with food reinforcement to discriminate between d-amphetamine and saline injections. Pharmacology, Biochemistry, and Behavior. 103: 168-73. PMID 22963928 DOI: 10.1016/J.Pbb.2012.08.026 |
0.761 |
|
2012 |
Panos JJ, Baker LE. Modulatory effects of low-dose MDMA on cocaine-induced locomotor activity and place conditioning in rats. Pharmacology, Biochemistry, and Behavior. 100: 377-81. PMID 21978942 DOI: 10.1016/J.Pbb.2011.09.007 |
0.776 |
|
2011 |
Peet MM, Baker LE. Salvinorin B derivatives, EOM-Sal B and MOM-Sal B, produce stimulus generalization in male Sprague-Dawley rats trained to discriminate salvinorin A. Behavioural Pharmacology. 22: 450-7. PMID 21814135 DOI: 10.1097/Fbp.0B013E328349Fc1B |
0.489 |
|
2010 |
Killinger BA, Peet MM, Baker LE. Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague-Dawley rats. Pharmacology, Biochemistry, and Behavior. 96: 260-5. PMID 20493209 DOI: 10.1016/J.Pbb.2010.05.014 |
0.469 |
|
2010 |
Panos JJ, Baker LE. An in vivo microdialysis assessment of concurrent MDMA and cocaine administration in Sprague-Dawley rats. Psychopharmacology. 209: 95-102. PMID 20112010 DOI: 10.1007/S00213-009-1774-2 |
0.754 |
|
2009 |
Baker LE, Panos JJ, Killinger BA, Peet MM, Bell LM, Haliw LA, Walker SL. Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats. Psychopharmacology. 203: 203-11. PMID 19153716 DOI: 10.1007/S00213-008-1458-3 |
0.751 |
|
2008 |
Poling A, Morgan-Paisley K, Panos JJ, Kim EM, O'Hare E, Cleary JP, Lesné S, Ashe KH, Porritt M, Baker LE. Oligomers of the amyloid-beta protein disrupt working memory: confirmation with two behavioral procedures. Behavioural Brain Research. 193: 230-4. PMID 18585407 DOI: 10.1016/J.Bbr.2008.06.001 |
0.629 |
|
2008 |
Baker LE, Searcy GD, Pynnonen DM, Poling A. Differentiating the discriminative stimulus effects of gamma-hydroxybutyrate and ethanol in a three-choice drug discrimination procedure in rats. Pharmacology, Biochemistry, and Behavior. 89: 598-607. PMID 18374971 DOI: 10.1016/J.Pbb.2008.02.016 |
0.483 |
|
2008 |
Kueh D, Iwamoto K, Poling A, Baker LE. Effects of gamma-hydroxybutyrate (GHB) and its metabolic precursors on delayed-matching-to-position performance in rats. Pharmacology, Biochemistry, and Behavior. 89: 179-87. PMID 18201754 DOI: 10.1016/J.Pbb.2007.12.007 |
0.779 |
|
2008 |
Laraway S, Snycerski S, Baker LE, Poling A. Gamma-hydroxybutyrate (GHB) reduces operant behavior without impairing working memory in rats responding under fixed-consecutive-number schedules. Pharmacology, Biochemistry, and Behavior. 88: 205-12. PMID 17904624 DOI: 10.1016/J.Pbb.2007.08.002 |
0.406 |
|
2007 |
Kueh D, Baker LE. Reinforcement schedule effects in rats trained to discriminate 3,4-methylenedioxymethamphetamine (MDMA) or cocaine. Psychopharmacology. 189: 447-57. PMID 17019568 DOI: 10.1007/S00213-006-0523-Z |
0.818 |
|
2005 |
Baker LE, Van Tilburg TJ, Brandt AE, Poling A. Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) and its metabolic precursor, gamma-butyrolactone (GBL) in rats. Psychopharmacology. 181: 458-66. PMID 16001124 DOI: 10.1007/S00213-005-0003-X |
0.554 |
|
2004 |
Baker LE, Pynnonen D, Poling A. Influence of reinforcer type and route of administration on gamma-hydroxybutyrate discrimination in rats. Psychopharmacology. 174: 220-7. PMID 14991222 DOI: 10.1007/S00213-003-1744-Z |
0.49 |
|
2004 |
Prus AJ, Baker LE, Meltzer HY. Discriminative stimulus properties of 1.25 and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanisms. Pharmacology, Biochemistry, and Behavior. 77: 199-208. PMID 14751446 DOI: 10.1016/J.Pbb.2003.10.010 |
0.607 |
|
2003 |
Goodwin AK, Pynnonen DM, Baker LE. Serotonergic-dopaminergic mediation of MDMA's discriminative stimulus effects in a three-choice discrimination. Pharmacology, Biochemistry, and Behavior. 74: 987-95. PMID 12667914 DOI: 10.1016/S0091-3057(03)00029-7 |
0.792 |
|
2002 |
Goodwin AK, Baker LE. An analysis of the utility of differential outcome procedures in drug discrimination research. Behavioural Pharmacology. 13: 271-8. PMID 12218507 DOI: 10.1097/00008877-200207000-00003 |
0.735 |
|
2002 |
Baker LE, Prus AJ. Reevaluation of PNU-99194A discriminative stimulus effects: potentiation by both a D2 antagonist and a D3/D2 agonist. Pharmacology, Biochemistry, and Behavior. 73: 753-8. PMID 12213519 DOI: 10.1016/S0091-3057(02)00882-1 |
0.422 |
|
2001 |
Goudie AJ, Baker LE, Smith JA, Prus AJ, Svensson KA, Cortes-Burgos LA, Wong EH, Haadsma-Svensson S. Common discriminative stimulus properties in rats of muscarinic antagonists, clozapine and the D3 preferring antagonist PNU-99194a: an analysis of possible mechanisms. Behavioural Pharmacology. 12: 303-15. PMID 11710745 DOI: 10.1097/00008877-200109000-00001 |
0.395 |
|
2001 |
Christian AJ, Goodwin AK, Baker LE. Antagonism of the discriminative stimulus effects of (+)-7-OH-DPAT by remoxipride but not PNU-99194A. Pharmacology, Biochemistry, and Behavior. 68: 371-7. PMID 11325388 DOI: 10.1016/S0091-3057(00)00470-6 |
0.769 |
|
2000 |
Goodwin AK, Baker LE. A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (+/-)-MDMA in rats. Experimental and Clinical Psychopharmacology. 8: 415-23. PMID 10975633 DOI: 10.1037//1064-1297.8.3.415 |
0.787 |
|
2000 |
Byrne T, Baker LE, Poling A. MDMA and learning: effects of acute and neurotoxic exposure in the rat. Pharmacology, Biochemistry, and Behavior. 66: 501-8. PMID 10899362 DOI: 10.1016/S0091-3057(00)00227-6 |
0.484 |
|
1999 |
Virden TB, Baker LE. Disruption of the discriminative stimulus effects of S(+)-3,4-methylenedioxymethamphetamine (MDMA) by (+/-)-MDMA neurotoxicity: protection by fluoxetine. Behavioural Pharmacology. 10: 195-204. PMID 10780832 DOI: 10.1097/00008877-199903000-00008 |
0.54 |
|
1999 |
Baker LE, Hood CA, Heidema AM. Assessment of D3 versus D2 receptor modulation of the discriminative stimulus effects of (+)-7-OH-DPAT in rats. Behavioural Pharmacology. 10: 717-22. PMID 10780286 DOI: 10.1097/00008877-199912000-00002 |
0.481 |
|
1999 |
Garner KJ, Baker LE. Analysis of D2 and D3 receptor-selective ligands in rats trained to discriminate cocaine from saline. Pharmacology, Biochemistry, and Behavior. 64: 373-8. PMID 10515316 DOI: 10.1016/S0091-3057(99)00064-7 |
0.574 |
|
1998 |
Baker LE, Svensson KA, Garner KJ, Goodwin AK. The dopamine D3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for D-amphetamine or cocaine. European Journal of Pharmacology. 358: 101-9. PMID 9808258 DOI: 10.1016/S0014-2999(98)00582-2 |
0.786 |
|
1998 |
Franklin SR, Baker LE, Svensson KA. Discriminative stimulus properties of the dopamine D3 antagonist PNU-99194A. Psychopharmacology. 138: 40-6. PMID 9694525 DOI: 10.1007/S002130050643 |
0.526 |
|
1998 |
Baker LE. (+)-7-OH-DPAT PRODUCES STIMULUS GENERALIZATION IN RATS TRAINED TO DISCRIMINATE d-AMPHETAMINE Behavioural Pharmacology. 9: S104. DOI: 10.1097/00008877-199808000-00240 |
0.389 |
|
1997 |
Baker LE, Miller ME, Svensson KA. Assessment of the discriminative stimulus effects of the D3 dopamine antagonist PNU-99194A in rats: comparison with psychomotor stimulants. Behavioural Pharmacology. 8: 243-52. PMID 9833019 |
0.523 |
|
1997 |
Morgan TB, Baker LE. The application of differential outcomes to a cocaine--saline discrimination procedure. Behavioural Pharmacology. 8: 31-6. PMID 9832998 DOI: 10.1097/00008877-199702000-00003 |
0.487 |
|
1997 |
Baker LE, Virden TB, Miller ME, Sullivan CL. Time course analysis of the discriminative stimulus effects of the optical isomers of 3,4-methylenedioxymethamphetamine (MDMA). Pharmacology, Biochemistry, and Behavior. 58: 505-16. PMID 9300612 DOI: 10.1016/S0091-3057(97)00287-6 |
0.506 |
|
1997 |
Baker LE, Taylor MM. Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination. Pharmacology, Biochemistry, and Behavior. 57: 737-48. PMID 9259001 DOI: 10.1016/S0091-3057(96)00334-6 |
0.554 |
|
1996 |
Baker LE, Makhay MM. Effects of (+)-fenfluramine on 3,4-methylenedioxymethamphetamine (MDMA) discrimination in rats. Pharmacology, Biochemistry, and Behavior. 53: 455-61. PMID 8808158 DOI: 10.1016/0091-3057(95)02017-9 |
0.55 |
|
1995 |
Baker LE, Broadbent J, Michael EK, Matthews PK, Metosh CA, Saunders RB, West WB, Appel JB. Assessment of the discriminative stimulus effects of the optical isomers of ecstasy (3,4-methylenedioxymethamphetamine; MDMA). Behavioural Pharmacology. 6: 263-275. PMID 11224335 DOI: 10.1097/00008877-199504000-00007 |
0.767 |
|
1993 |
Baker LE, Riddle EE, Saunders RB, Appel JB. The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds. Behavioural Pharmacology. 4: 69-79. PMID 11224173 DOI: 10.1097/00008877-199302000-00008 |
0.654 |
|
1991 |
Appel JB, Baker LE, Barrett RL, Broadbent J, Michael EM, Riddle EE, Van Groll BJ. Use of drug discrimination in drug abuse research. Nida Research Monograph. 369-97. PMID 1369679 DOI: 10.1037/E496182006-023 |
0.581 |
|
Show low-probability matches. |